HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Blondeau, K. Articles by Dupont, L. J. Search for Related Content PubMed PubMed Citation Articles by Blondeau, K. Articles by Dupont, L. J.

Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection

¹ Centre for Gastroenterological Research, and ² Lung Transplant Unit, University Hospital Gasthuisberg, Katholieke Universiteit, Leuven, Belgium.

CORRESPONDENCE: L. J. Dupont, Division of Respiratory Medicine, University Hospital Gasthuisberg, 49 Herestraat, B-3000 Leuven, Belgium. Fax: 32 16346803. E-mail: lieven.dupont{at}uz.kuleuven.be

Keywords: Bronchiolitis obliterans syndrome, gastro-oesophageal reflux, transplantation

Received: May 30, 2007
Accepted November 22, 2007

Acid gastro-oesophageal reflux (GOR) and gastric aspiration have been labelled as risk factors for chronic rejection bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx). The present study aimed to further characterise GOR (both acid and nonacid) and the degree of gastric aspiration in LTx recipients both with and without BOS.

Impedance-pH recordings were used for GOR detection. Pepsin and bile acid levels were measured in bronchoalveolar lavage fluid (BALF).

A total of 48% of patients had increased GOR, of which 27% had exclusively increased nonacid reflux. Cystic fibrosis patients had the highest prevalence of GOR. Pepsin was found in BALF of all patients and bile acids in BALF of 50% of the patients. Patients with BOS had neither increased GOR nor elevated pepsin in BALF. However, 70% of the patients with BOS had bile in BALF compared with 31% of stable patients. Proton pump inhibitor (PPI) treatment reduced acid reflux but did not affect nonacid reflux. Moreover, pepsin and bile levels in BALF were not reduced by PPI.

One-half of the lung transplant patients had increased reflux, and nonacid reflux was common. Gastric aspiration occurred in most lung transplant patients. Pepsin was a more general marker and bile acids a more specific marker that might be associated with bronchiolitis obliterans syndrome. Proton pump inhibitor treatment did not prevent nonacid reflux and gastric aspiration.

This article has been cited by other articles:

				B. M. Vanaudenaerde, I. Meyts, R. Vos, N. Geudens, W. De Wever, E. K. Verbeken, D. E. Van Raemdonck, L. J. Dupont, and G. M. Verleden A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Eur. Respir. J., October 1, 2008; 32(4): 832 - 842. [Abstract] [Full Text] [PDF]